Suprin 2025: The debt structure after Series C and the real covenant headroom
Series C extended Suprin's maturity profile and added liquidity, but it did not remove the financing pressure point. Public bond covenants are currently comfortable, while the real test still sits at the asset and associate-company level.
What Series C actually changed
The main article already framed the core issue: with Suprin, the question is no longer only whether earnings recovered, but whether the business can fund the next phase without repeatedly leaning on the debt market. This follow-up isolates the narrower question that matters now: what Series C changed in the debt stack, and what remained unresolved even after the issuance.
The first change is structural. After Series C, Suprin's listed debt is no longer just one convertible layer plus one secured bond series. It is now a three-layer stack: Series A is convertible, Series B is secured, and Series C is unsecured and was issued together with warrants. In par-value terms, listed bond debt increased from ILS 223.94 million before Series C to ILS 310.91 million after it. That is an increase of almost 39%.
The immediate implication is positive: duration improved. Series C adds no principal repayment in 2026, and its amortization runs through March 2033. That reshapes the maturity wall and pushes part of it into later years.
But that is a real easing of pressure, not a removal of the near wall. At year-end 2025, the company already faced current bond maturities of ILS 30.485 million alongside ILS 41.669 million of short-term bank debt. Series C improved the forward profile, but it did not erase the fact that 2026 starts with a meaningful short-term funding load.
The second point matters even more: the proceeds were not ring-fenced for one deleveraging purpose. They were intended for acquisitions and development of properties and land, refinancing existing debt, and funding ongoing operations, while the board retained the ability to reallocate them over time. That makes Series C less of a pure deleveraging move and more of a financing-flexibility move. In practice, the issuance generated net proceeds of about ILS 82.157 million. That is roughly the same magnitude as Suprin's negative operating cash flow in 2025, which came in at ILS 77.816 million. In other words, the market gave Suprin time. It did not yet prove that the business has become self-funding.
Public covenants are comfortable, but they test equity rather than cash
This is where the gap opens between the headline impression and the actual evidence. It is easy to see new debt, a difficult real-estate backdrop, and conclude that the company must be moving closer to covenants. That is not the picture here.
Series C carries a fixed 6.5% coupon, is unrated, and is unsecured. Its hard financial covenants do not test cash flow, debt-service coverage, NOI, or a cash leverage metric. They test only two holdco-level measures: minimum solo equity of ILS 90 million, and a solo equity-to-balance-sheet ratio of at least 22.5%. More importantly, the coupon step-up starts before the actual breach line, once solo equity drops below ILS 100 million or the solo equity-to-assets ratio drops below 26%.
| Test | Coupon step-up line | Breach line | Actual at 31 Dec 2025 | Headroom |
|---|---|---|---|---|
| Solo equity | ILS 100m | ILS 90m | ILS 156m | ILS 56m above the step-up line, ILS 66m above the breach line |
| Solo equity / solo assets | 26% | 22.5% | 41% | 15 percentage points above the step-up line, 18.5 points above the breach line |
If one threshold is breached, the coupon increases by 0.25%. If both are breached, the increase reaches 0.5%. That matters, but it also reveals something deeper: Suprin's public covenant headroom is an equity cushion, not a cash cushion. The company can remain far from a Series C covenant breach even while cash generation remains under pressure, as long as solo equity stays comfortably above the thresholds.
That pattern is not limited to Series C. The older public series are also far from their triggers. Series A is tested against minimum solo equity of ILS 80 million and a minimum solo equity ratio of 22.5%. Series B is tested against minimum solo equity of ILS 90 million, a minimum solo equity ratio of 22.5%, a minimum consolidated equity ratio of 20%, a debt-to-collateral cap of 75%, and a minimum self-resources ratio at Suprin Nechasim of 20%. At 31 December 2025, actual figures were ILS 156 million of solo equity, 41% solo equity ratio, 32.2% consolidated equity ratio, 61.64% Series B debt-to-collateral, and 46% self-resources ratio at Suprin Nechasim.
That matters. At the level of public bonds, Suprin does not look like a company brushing against the walls. Quite the opposite. It looks like a company whose public covenants are designed to bite late. For bondholders, that is reassuring in the short term. For equity holders, it also explains why covenant comfort is not the same thing as cash comfort.
Where the pressure actually sits
The pressure did not disappear. It sits lower in the structure, at the asset and associate-company level.
That comes through most clearly in the note on Nichsei Pandum Habarzel. There, the banking package includes three tests: tangible equity of at least 30.6% of the balance sheet, a collateral ratio not above 67%, and a cumulative ratio of debt and liabilities to the bank over cumulative NOI not above 10. At 31 December 2025 the associate did not comply with the third test, a breach that could have triggered immediate repayment of the loan. After the balance-sheet date it received a bank waiver until 30 April 2026, while also receiving proposals from several banks for refinancing.
This is not background noise. It is the clearest illustration of the difference between accounting headroom at the public-company level and real financing headroom at the asset level. The parent company remains comfortably inside the public bond covenants. At the same time, an associate already needed a waiver and is now pursuing refinancing. So the key question is not whether Series C moved Suprin away from a public-deed breach. It clearly did. The key question is whether it reduced dependence on continued access to bond-market and bank funding. There, the answer is still much more qualified.
The broader structure points the same way. According to the debt breakdown in the annual report, debt at the company and consolidated-subsidiary level stood at roughly ILS 270.6 million at year-end 2025 and about ILS 352.7 million near the report date after Series C. At the same time, debt at associates, on a fully chained look-through basis, stood at about ILS 152.1 million at year-end 2025 and about ILS 159.3 million near the report date. A meaningful part of financing risk therefore sits outside the consolidated shell, but not outside the group's underlying economics.
Dilution exists, but the equity is still conditional
Series C changed not only duration, but also the dilution profile. It was issued together with 1,739,320 Series 1 warrants, each exercisable into one ordinary share at an exercise price of ILS 10. Full exercise would imply potential equity cash proceeds of about ILS 17.4 million for the company.
That sounds like a useful cushion, but for now it remains a theoretical one. As of 3 April 2026 the share price stood at 696.6 agorot, below the ILS 10 strike price. So the warrant layer is not currently available equity capital. It is a potential future source of capital and a potential future dilution event. If the share price moves above the strike, the company gets additional equity and the liability side becomes a little less one-sided. If not, shareholders are left with debt that has already been raised and warrants that did not actually finance the balance sheet.
In that sense, Series C is more convenient than an immediate equity raise, but it is not free. It pushes part of the equity question to a later point, when the market will decide whether the stock is strong enough to trigger exercise.
Bottom line
Series C bought Suprin time, not independence. It extended the amortization profile, increased liquidity, and left the public covenant package at a comfortable distance from breach. But it did not change the fact that the new debt came with flexible use of proceeds rather than a hard deleveraging commitment, and it did not remove the fact that the first real financing warning sign already appeared at the associate level through a bank waiver.
That is why the covenant headroom is real, but should be read correctly. It is real against the public bond deeds, because those tests are built around equity rather than cash. It is less convincing if one tries to treat it as proof of full financing independence across the operating stack. As long as project receivables have not turned into cash, and as long as refinancing at the asset level remains necessary, Suprin still depends on the debt market more than it is free from it.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.